Discussion
Approved treatments
for hypoparathyroidism
Yorvipath
Yorvipath (palopegteriparatide) is an approved daily hormone replacement therapy for the management of blood calcium levels in adults with hypoparathyroidism. It is given once a day by subcutaneous (under-the-skin) injection.